According to TipRanks, Kaplan is a 2-star analyst with an average return of -0.7% and a 48.68% success rate. Kaplan covers the Services sector, focusing on stocks such as Equifax, Bright Horizons, and Republic Services.
Currently, the analyst consensus on Clarivate is a Strong Buy with an average price target of $12.93, a 37.12% upside from current levels. In a report released today, Goldman Sachs also maintained a Buy rating on the stock with a $14.50 price target.
The company has a one-year high of $25.63 and a one-year low of $8.00. Currently, Clarivate has an average volume of 7.36M.
Based on the recent corporate insider activity of 81 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CLVT in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Clarivate Analytics Plc provides trusted insights and analytics to accelerate the pace of innovation. Its solutions include scientific and research, patent intelligence and compliance standards, pharmaceutical and biotech intelligence and trademark, domain and brand protection. The company product portfolio includes Life Science, Web of Science, Cortellis, Derwent, CompuMark, MarkMonitor and Techstreet. It helps clients to reduce the time from new ideas to life changing innovations. The company was founded in 1864 and is headquartered in St. Helier, Jersey.
Read More on CLVT: